Ildong, KR7249420001

Ildong launches Superamin while KRW 433.2 billion values Ildong stock

Published on 10/20/2026 at 01:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Superamin launched with products containing 17 and 19 ingredients on October 14, 2026. Ildong stock is tied to Q2 revenue of KRW 147.9 billion.

Commercial rollout and operating figures

  • Superamin launched on October 14, 2026, with products containing 17 and 19 ingredients.
  • Second-quarter revenue reached KRW 147.9 billion, up 6.8 percent year over year.
  • Ildong stock was last at KRW 13,750.00 on October 19, 2026, with a KRW 433.2 billion market capitalization.
Ildong, KR7249420001, Illustration mit AI erstellt.

Ildong (KR7249420001) launched its SUPERAMIN vitamin brand on October 14, 2026, introducing two products with 17 and 19 ingredients, respectively, according to Chosunbiz. Ildong stock was last at KRW 13,750.00 on October 19, 2026, while its market capitalization stood at KRW 433.2 billion.

Three dated moves shape the story

On September 30, 2026, Ildong agreed to acquire a 13.95 percent stake in Idience for KRW 36.8 billion, with completion expected on October 7, 2026, as reported by MarketScreener. On October 12, 2026, the company used CPHI Worldwide in Milan to discuss exports, contract manufacturing and technology transfers, with production facilities in Anseong and Cheongju, according to Edaily. On October 14, 2026, it launched SUPERAMIN Urs and SUPERAMIN Quattro, containing 17 and 19 ingredients, respectively, according to Chosunbiz.

What does the launch mean for margins?

The vitamin rollout adds a consumer-health product line, but the latest reported figures point to profitability as the key measure. In the second quarter of 2026, revenue reached KRW 147.9 billion, up 6.8 percent from KRW 138.5 billion a year earlier, while operating profit was KRW 2.0 billion, according to Awakeplus. The figures imply a 1.3 percent operating margin for the quarter, leaving the brand launch to prove its commercial value through sales and profit conversion.

Next filing date is November 16

The next dated reporting milestone is November 16, 2026, the filing deadline for the period ending September 30, 2026, according to Atsview. That date will provide the next formal checkpoint for revenue, operating profit and the contribution of newer consumer-health products.

Market value and trading context

Ildong stock was last at KRW 13,750.00 on the Korea Exchange on October 19, 2026 at 3:30 p.m. KST. The same quote showed a 52-week range of KRW 11,250.00 to KRW 45,050.00 and a market capitalization of KRW 433.2 billion, placing the latest price materially below the yearly high.

Ildong stock key data

  • Company: Ildong Pharmaceutical Co., Ltd.
  • ISIN: KR7249420001
  • Ticker: 249420
  • Primary exchange: Korea Exchange
  • Market capitalization: KRW 433.2 billion (as of October 19, 2026)
  • 52-week range: KRW 11,250.00-45,050.00 (as of October 19, 2026)
  • Sector / Industry: Pharmaceuticals

Market context: Market report KOSPI.

More news and analyses on Ildong stock

Disclaimer...
en | KR7249420001 | ILDONG | boerse | 70367622 | bgmi